ClinicalTrials.Veeva

Menu

Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Profound Multiple Intellectual Disabilities

Treatments

Behavioral: Test at 6 months
Behavioral: Test-retest at the end of 2 weeks
Behavioral: Visual-behavioral Scale at day 1

Study type

Observational

Funder types

Other

Identifiers

NCT03040609
P140712
RCB: 2016-A00278-43 (Other Identifier)

Details and patient eligibility

About

The main objective of this study is to develop and validate a visio-behavioral scale of visual abilities for subjects with profound multiple intellectual disabilities.

The secondary objectives of the study are:

  • to validate the structure of the scale.
  • to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.
  • to evaluate the feasibility of visio-behavioral scale.
  • to evaluate the sensitivity to change.
  • to study the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).
  • to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.

Full description

This study includes 3 phases:

  • Elaboration of a list of behavioral items by a group of multi-disciplinary expertise (physicians, nurses, caregivers, ophthalmologies, orthoptists) based on their clinical experiences.
  • Development of the scale based on the sample obtained by a prospective multicenter research trial.
  • Validation of the sample obtained by a prospective transversal multicenter study.

This study will be performed in 5 centers in France. The enrollment of patients planned for 24 months targeting 310 patients. The duration of follow-up of the study for each patient will be varied according to the group of patients, il will be 1 day for group 1, 2 weeks for group 2, or 6 months for group 3.

Enrollment

232 patients

Sex

All

Ages

3+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Causal brain injury occurred before the age of 3 years.
  • Severe or deep mental retardation as defined by DSM IV.
  • Motor impairment: para / tetraparesis, hemiparesis, ataxia, or extrapyramidal motor disorders.
  • Score of Gross Motor Function Classification System [Palisano 1997] is III, IV or V.
  • Score of Functional Independence Measure < 55.
  • Subject aged ≥3 years (because the visio-behavioral scale is not adapted for children younger than 3 years).
  • Beneficiary of a social protection.
  • Written consent signed by guardian or legal representative, or parents in case of a minor subject.

Exclusion criteria

  • Acute intercurrent pathology precluding examinations.
  • Patient with hypersensitivity to tropicamide, atropine or benzalkonium chloride.
  • Angle closure glaucoma suspect patient.
  • Patient with severe hypertension.
  • Short life expectancy.

Trial design

232 participants in 3 patient groups

Group 1
Description:
The duration of follow-up of group 1 in the study is 1 day.
Treatment:
Behavioral: Test-retest at the end of 2 weeks
Behavioral: Test at 6 months
Behavioral: Visual-behavioral Scale at day 1
Group 2
Description:
The duration of follow-up of group 2 in the study is 2 weeks.
Treatment:
Behavioral: Test-retest at the end of 2 weeks
Behavioral: Test at 6 months
Group 3
Description:
The duration of follow-up of group 3 in the study is 6 months.
Treatment:
Behavioral: Test at 6 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems